258 related articles for article (PubMed ID: 26045734)
1. Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma.
Saito T; Mitomi H; Yao T
Int J Clin Exp Pathol; 2015; 8(3):2267-73. PubMed ID: 26045734
[TBL] [Abstract][Full Text] [Related]
2. PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma.
Saito T; Mitomi H; Imamhasan A; Hayashi T; Kurisaki-Arakawa A; Mitani K; Takahashi M; Kajiyama Y; Yao T
Mutagenesis; 2015 Mar; 30(2):297-301. PubMed ID: 25395299
[TBL] [Abstract][Full Text] [Related]
3. Personalized targeted therapy for esophageal squamous cell carcinoma.
Kang X; Chen K; Li Y; Li J; D'Amico TA; Chen X
World J Gastroenterol; 2015 Jul; 21(25):7648-58. PubMed ID: 26167067
[TBL] [Abstract][Full Text] [Related]
4. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
[TBL] [Abstract][Full Text] [Related]
5. Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation.
Baba Y; Ishimoto T; Harada K; Kosumi K; Murata A; Miyake K; Hiyoshi Y; Kurashige J; Iwatsuki M; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Oki E; Iyama K; Watanabe M; Baba H
Ann Surg Oncol; 2015 Oct; 22(11):3659-65. PubMed ID: 25691283
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.
Saito T; Mitomi H; Imamhasan A; Hayashi T; Mitani K; Takahashi M; Kajiyama Y; Yao T
Virchows Arch; 2014 Feb; 464(2):135-43. PubMed ID: 24464051
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.
Sarbia M; Loberg C; Wolter M; Arjumand J; Heep H; Reifenberger G; Gabbert HE
Am J Pathol; 1999 Oct; 155(4):1027-32. PubMed ID: 10514383
[TBL] [Abstract][Full Text] [Related]
8. Integrated molecular characterization of esophageal basaloid squamous cell carcinoma: a subtype with distinct RNA expression pattern and immune characteristics, but no specific genetic mutations.
Li Y; Liu L; Pan Y; Fang F; Xie T; Cheng N; Guo C; Xue X; Zeng H; Xue L
J Pathol; 2023 Feb; 259(2):136-148. PubMed ID: 36371676
[TBL] [Abstract][Full Text] [Related]
9. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
[TBL] [Abstract][Full Text] [Related]
10. Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review.
Liu L; Xue X; Xue L
Diagn Pathol; 2019 Sep; 14(1):102. PubMed ID: 31488173
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
12. Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers.
Bellizzi AM; Woodford RL; Moskaluk CA; Jones DR; Kozower BD; Stelow EB
Am J Surg Pathol; 2009 Nov; 33(11):1608-14. PubMed ID: 19738459
[TBL] [Abstract][Full Text] [Related]
13. Basaloid squamous cell carcinoma of the esophagus.
Chen SB; Weng HR; Wang G; Yang JS; Yang WP; Li H; Liu DT; Chen YP
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1165-71. PubMed ID: 22419439
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
[TBL] [Abstract][Full Text] [Related]
15. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
Lam KY; Law S; Luk JM; Wong J
J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study.
Owonikoko T; Loberg C; Gabbert HE; Sarbia M
J Pathol; 2001 Feb; 193(2):155-61. PubMed ID: 11180160
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression.
Sato-Kuwabara Y; Fregnani JH; Jampietro J; Carvalho KC; Franco CP; da Costa WL; Coimbra FJ; Soares FA
Tumour Biol; 2016 May; 37(5):6691-9. PubMed ID: 26649862
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma.
Kim HS; Kim SM; Kim H; Pyo KH; Sun JM; Ahn MJ; Park K; Keam B; Kwon NJ; Yun HJ; Kim HG; Chung IJ; Lee JS; Lee KH; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Kim HR; Moon YW; Lee YC; Kim JH; Paik S; Cho BC
Oncotarget; 2015 Dec; 6(42):44971-84. PubMed ID: 26462025
[TBL] [Abstract][Full Text] [Related]
20. Basaloid squamous cell carcinoma of the oral cavity: an analysis of 92 cases.
Fritsch VA; Gerry DR; Lentsch EJ
Laryngoscope; 2014 Jul; 124(7):1573-8. PubMed ID: 23946211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
